| 摘要 |
The invention relates to methods of determining, in respect of a female subject, the risk of developing a cardiovascular event, such as coronary artery disease, by measuring SerpinF2 protein levels in a bodily fluid sample comprising exosomes from said female subject and determining whether said level indicates whether said female subject is at risk of developing a cardiovascular event. |
